ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Patient education, evidence-based treatment and biomarkers in HFrEF"
Episode Synopsis
touchPANEL DISCUSSION for touchCARDIO
Listen to leading experts discuss how patients can be best supported following a diagnosis of HFrEF, how to implement evidence-based therapies into practice including the potential impact of emerging therapies on treatment selection, and the role of biomarkers in diagnosing, monitoring and determining treatment course for individuals with HFrEF.
The experts
Prof. Piotr Ponikowski, Wrocław Medical University, Wrocław, Poland
Prof. Adriaan A Voors, University Medical Centre Groningen, Groningen, The Netherlands
Dr Stephen Greene, Duke University, Durham, NC, USA
This touchPODCAST is for HCPs only.
Funding for this touchPODCAST is from an unrestricted independent educational grant from Bayer, Merck & Co and AstraZeneca. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchcardioime.org/aiming-for-improved-outcomes-in-hfref
Listen to leading experts discuss how patients can be best supported following a diagnosis of HFrEF, how to implement evidence-based therapies into practice including the potential impact of emerging therapies on treatment selection, and the role of biomarkers in diagnosing, monitoring and determining treatment course for individuals with HFrEF.
The experts
Prof. Piotr Ponikowski, Wrocław Medical University, Wrocław, Poland
Prof. Adriaan A Voors, University Medical Centre Groningen, Groningen, The Netherlands
Dr Stephen Greene, Duke University, Durham, NC, USA
This touchPODCAST is for HCPs only.
Funding for this touchPODCAST is from an unrestricted independent educational grant from Bayer, Merck & Co and AstraZeneca. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchcardioime.org/aiming-for-improved-outcomes-in-hfref
In God we trust